文献速递腹部CTMR

人工智能在肝细胞癌预后评估中的应用

Prognostication of Hepatocellular Carcinoma Using Artificial Intelligence.
PubMed 文献 · Korean J Radiol · 2024-01-01

肝细胞癌生物学异质性导致预后差异大,传统影像预后评估依赖主观视觉征象且观察者间变异大。本文综述基于影像组学和深度学习的人工智能方法利用大量定量影像特征,在预测微血管侵犯、局部治疗后复发风险及系统治疗反应等方面的潜在价值,并讨论其局限性与未来前景。

要点

  • 人工智能基于影像组学或深度学习提取大量定量特征,可对肿瘤表型进行客观、详细、全面的分析。
  • 影像组学在预测肝细胞癌微血管侵犯、局部治疗后复发风险及系统治疗反应方面显示出潜力。
  • 传统影像预后评估依赖视觉判读的预后征象,受主观性和观察者间变异限制。

核心结论

  • 人工智能尤其是影像组学在肝细胞癌预后评估中显示出潜力,包括预测微血管侵犯、局部治疗后复发风险及系统治疗反应。

研究设计与样本

  • 综述,检索范围与纳入文献原文未报告。

局限性

  • 传统影像预后评估方法基于视觉判读的预后征象,受主观性和观察者间变异限制。
  • 原文指出人工智能在肝细胞癌预后评估中存在局限性,但未具体列出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Hepatocellular carcinoma (HCC) is a biologically heterogeneous tumor characterized by varying degrees of aggressiveness. The current treatment strategy for HCC is predominantly determined by the overall tumor burden, and does not address the diverse prognoses of patients with HCC owing to its heterogeneity. Therefore, the prognostication of HCC using imaging data is crucial for optimizing patient management. Although some radiologic features have been demonstrated to be indicative of the biologic behavior of HCC, traditional radiologic methods for HCC prognostication are based on visually-assessed prognostic findings, and are limited by subjectivity and inter-observer variability. Consequently, artificial intelligence has emerged as a promising method for image-based prognostication of HCC. Unlike traditional radiologic image analysis, artificial intelligence based on radiomics or deep learning utilizes numerous image-derived quantitative features, potentially offering an objective, detailed, and comprehensive analysis of the tumor phenotypes. Artificial intelligence, particularly radiomics has displayed potential in a variety of applications, including the prediction of microvascular invasion, recurrence risk after locoregional treatment, and response to systemic therapy. This review highlights the potential value of artificial intelligence in the prognostication of HCC as well as its limitations and future prospects.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Heo S, Park HJ, Lee SS, et al. Prognostication of Hepatocellular Carcinoma Using Artificial Intelligence. Korean J Radiol. 2024. PMID: 38807336. doi:10.3348/kjr.2024.0070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。